Check a quit-vaping research invitation before sharing your history

Separate identity from a persuasive message

A flyer can describe a promising goal while leaving its sender unclear. Note the study title, institution and contact details it claims. Check the institution’s own website or a known official route instead of treating the invitation’s link, logo or urgency as proof of identity.

The FTC advises checking unexpected messages through independently known company contacts. Apply that verification habit here without labeling every research invitation a scam. If the institution cannot confirm the project, keep personal information private while you clarify what the message represents.

US Federal Trade Commission: How To Recognize and Avoid Phishing Scams

Ask what participation actually involves

OHRP’s public questions cover a study’s purpose, procedures and who handles concerns. Use its list to prepare your own questions rather than assuming that “quit study” means ordinary care. This article does not recommend enrollment, determine eligibility or assess an intervention’s risks for you.

For an initial administrative inquiry, you can say: “I received an invitation using this study title. Is this your project, and where can I read the participation information?” Avoid sending a full tracker export or photographs of documents simply to establish who sent the invitation.

US Department of Health and Human Services — OHRP: Questions to Ask About Volunteering for a Research Study

Compare the details across official records

If a study record is available, compare its institution, study identifier and contact with the information the institution gives you. Similar titles can refer to different projects. A registry record describes research; its existence does not prove that an invitation is genuine or that a program is effective.

An illustrative discrepancy is an invitation claiming immediate public results while the official project contact says data collection continues. Ask the team to explain the discrepancy. Do not invent a benefit from the invitation’s wording or substitute an old news story for current participation information.

NIH MedlinePlus Magazine — US National Library of Medicine: ClinicalTrials.gov

Keep the decision open until your questions are answered

Ask how much time you have to decide and which person can answer individual questions. Keep any existing professional support separate while considering research. A refusal to join does not need to become a statement about whether you want to quit.

The output of this check is a verified contact and a question list, not a clearance to participate. If you still cannot identify the responsible institution or understand the request, do not fill the gap with assumptions. Qualified study staff and your appropriate care contacts must address personal participation decisions.